STSS

+ Watchlist + Portfolio

Sharps Technology Inc.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Fundamentals are temporarily unavailable for STSS.

STSS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$0.00	$0.00	$0.00	$204.12K
Cost of Revenue	—	—	$0.00	$617.45K
Gross Profit	—	—	$0.00	-$413.32K
Research & Development	$2.28M	$1.61M	$531.23K	$198.76K
Selling, General & Admin	$6.46M	$8.52M	$5.04M	$19.49M
Operating Expenses	$8.74M	$10.13M	$5.57M	$12.88M
Operating Income	-$8.74M	-$10.13M	-$5.57M	-$13.29M
EBITDA	-$8.08M	-$9.24M	-$3.52M	-$269.79M
Pretax Income	-$4.64M	-$9.87M	-$5.23M	-$270.34M
Income Tax	$0.00	-$30.00K	$0.00	$0.00
Net Income	-$4.64M	-$9.84M	-$9.30M	-$282.50M
Diluted EPS	-3762.00	-4983.00	-2219.92	-11.16
Diluted Shares	1227	1974	4188	25.31M

STSS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$4.17M	$3.01M	$754.80K	$10.38M
Receivables	—	$47.95K	$0.00	$711.96K
Inventory	$185.80K	$1.71M	$538.83K	$645.27K
Current Assets	$4.42M	$4.84M	$3.17M	$18.88M
Total Assets	$11.84M	$11.79M	$7.31M	$269.08M
Current Liabilities	$2.01M	$3.69M	$5.19M	$4.70M
Total Debt	—	—	$3.76M	$3.08M
Total Liabilities	$2.20M	$3.85M	$5.32M	$4.70M
Retained Earnings	-$15.31M	-$25.15M	-$34.45M	-$316.95M
Shareholders' Equity	$9.64M	$7.93M	$2.00M	$264.38M
Working Capital	$2.42M	$1.15M	-$2.01M	$14.19M
Net Debt	—	—	$3.01M	—

STSS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$6.43M	-$8.51M	-$4.40M	-$10.99M
Capital Expenditure	-$752.34K	-$698.28K	-$138.80K	-$170.52M
Free Cash Flow	-$7.19M	-$9.21M	-$4.40M	-$181.51M
Depreciation & Amortisation	$654.57K	$882.18K	$37.52K	$132.54K
Stock-Based Compensation	$1.01M	$963.02K	$520.83K	$107.47M
Investing Cash Flow	-$3.12M	-$698.28K	-$1.00M	-$187.52M
Financing Cash Flow	$12.24M	$8.03M	$5.91M	$215.51M
Net Change in Cash	$2.68M	-$1.18M	$506.01K	$17.00M

STSS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$0.00	$222.72K	$83.62K	-$102.22K	$192.78K
Cost of Revenue	$0.00	$1.25M	$1.25M	-$1.89M	$202.58K
Gross Profit	$0.00	-$1.03M	-$1.17M	$1.79M	-$9.80K
Research & Development	$0.00	$61.45K	$152.11K	-$96.82K	$137.10K
Selling, General & Admin	$1.36M	$1.91M	$110.72M	-$95.09M	$7.55M
Operating Expenses	$1.36M	$1.97M	$109.48M	-$100.59M	$4.56M
Operating Income	-$1.36M	-$3.01M	-$110.65M	$102.38M	-$4.57M
EBITDA	-$1.31M	-$2.79M	-$110.50M	-$154.24M	-$4.54M
Pretax Income	$2.63M	$3.56M	-$105.33M	-$170.49M	-$86.24M
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income	$1.93M	$3.56M	-$105.33M	-$182.66M	-$86.24M
Diluted EPS	38.63	3.58	-4.33	—	-1.19
Diluted Shares	49938	995212	24.34M	—	72.57M

STSS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$11.89M	$8.32M	$10.52M	$10.38M	$12.32M
Receivables	$160.19K	$439.42K	$1.47M	$711.96K	$718.47K
Inventory	$2.06M	$1.63M	$745.26K	$645.27K	$457.71K
Current Assets	$14.25M	$10.49M	$39.66M	$18.88M	$18.38M
Total Assets	$18.92M	$17.09M	$443.96M	$269.08M	$181.00M
Current Liabilities	$8.65M	$2.41M	$10.61M	$4.70M	$2.22M
Total Debt	—	—	$7.63M	$3.08M	—
Total Liabilities	$8.78M	$2.55M	$10.75M	$4.70M	$2.22M
Retained Earnings	-$32.52M	-$28.96M	-$134.29M	-$316.95M	-$403.19M
Shareholders' Equity	$10.14M	$14.54M	$433.21M	$264.38M	$178.78M
Working Capital	$5.60M	$8.08M	$29.05M	$14.19M	$16.16M

STSS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$1.42M	-$2.94M	-$7.39M	$752.88K	-$2.68M
Capital Expenditure	-$90.41K	-$1.87M	-$187.55M	—	—
Free Cash Flow	-$1.42M	-$4.90M	-$194.93M	$19.74M	-$2.68M
Depreciation & Amortisation	$55.10K	$216.22K	$145.63K	-$284.42K	$22.33K
Stock-Based Compensation	$44.38K	$288.11K	$104.63M	$2.50M	$2.23M
Investing Cash Flow	$0.00	-$1.96M	-$187.55M	$1.98M	$9.29M
Financing Cash Flow	$13.95M	$0.00	$196.77M	$4.78M	-$4.67M
Net Change in Cash	$12.54M	-$4.90M	$1.84M	$7.52M	$1.94M

Market Snapshot

About

Sharps Technology Inc. is a medical device company that develops and manufactures safety-engineered medical products. The company focuses on innovative solutions for the safe administration of injectable medications and vaccines. Their products are designed to prevent needlestick injuries and reduce exposure to bloodborne pathogens in healthcare settings.